References
- WHO.
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (Acessed 01 February 2024). - Ministério da Saúde, 2019. MS/SVS/CGIAE – Sistema de Informações sobre Mortalidade – SIM.
http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def (Acessed 01 February 2024). - Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, et al. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2023; 23:206. DOI: 10.1186/s12872-023-03231-w
- Basit H, Malik A, Huecker MR. Non-ST-segment elevation Myocardial Infarction. StatPearls. 2024. [Accessed online:
https://www.ncbi.nlm.nih.gov/books/NBK513228/ ] - Chapman AR, Lee KK, McAllister DA, Cullne L, Greenslade JH, Parsonage W, et al. Association of high-sensitivity cardiac Troponin I concentration with cardiac outcomes in patients with suspected Acute Coronary Syndrome. JAMA. 2017; 318(19):1913–1924. DOI: 10.1001/jama.2017.17488
- Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS, et al. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the evaluation and diagnosis of Acute Chest Pain. Circulation. 2022; 146:569–581. DOI: 10.1161/CIRCULATIONAHA.122.059678
- Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016; 37(3):267–315. DOI: 10.1016/j.rec.2015.10.009
- van der Linden N, Wildi K, Twerenbold R, Pickering JW, Than M, Cullen L, et al. Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018; 138(10):989–999. DOI: 10.1161/CIRCULATIONAHA.117.032003
- Chaulin A. Current characteristics of methods for determining cardiac troponins and their diagnostic value: A mini-review. Revista de la Facultad de Ciencias Medicas de Cordoba 2021; 78(4):415–422. DOI: 10.31053/1853.0605.v78.n4.32988
- Kavsak PA, Mondoux SE, Ainsworth C, Worster A. High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI. International Journal of Cardiology. 2022; 356:36–37. DOI: 10.1016/j.ijcard.2022.03.041
- Romano ER, Liguori ID, Farran JA, do Egito RMP, Romano MLP, Werneck VA, et al. Prognostic score for acute coronary syndrome in a private terciary hospital. Arquivos Brasileiros de Cardiologia. 2014; 102(3):226–236. DOI: 10.5935/abc.20140012
- Wereski R, Kimenai DM, Taggart C, Doudesis D, Lee KK, Lowry MTH, et al. Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction. Circulation. 2021; 144(7):528–538. DOI: 10.1161/CIRCULATIONAHA.121.054302
- Krychtiuk KA, Newby LK. High-sensitivity cardiac troponin assays: Ready for prime time! Annual Review of Medicine. 2024; 75:459–474. DOI: 10.1146/annurev-med-051022-113931
- Bhatnagar D, Kaur I, Kumar A. Ultrasensitive cardiac troponin I antibody based nanohybrid sensor for rapid detection of human heart attack. International Journal of Biological Macromolecules. 2017; 95:505–510. DOI: 10.1016/j.ijbiomac.2016.11.037
- Periyakaruppan A, Gandhiraman RP, Meyyappan M, Koehne JE. Label-free detection of cardiac troponin-I using carbon nanofiber based nanoelectrode arrays. Anaytical Chemistry. 2013; 85(8):3858–3863. DOI: 10.1021/ac302801z
- Neumann JT, Sörensen NA, Ojeda F, Renné T, Schnabel RB, Zeller T, et al. Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PLoS One. 2017; 12(3):
e0174288 . DOI: 10.1371/journal.pone.0174288 - Silva PGMBE, Berwanger O, Santos ESD, Sousa ACS, Cavalcante MA, Andrade PB, et al. One year follow-up assessment of patients included in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Arq Bras Cardiol. 2020; 114(6):995–1003. DOI: 10.36660/abc.20190879
- Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Gimenez MR, Badertscher P, et al. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clinical Biochemistry. 2018; 53:143–155. DOI: 10.1016/j.clinbiochem.2017.12.006
- Tang L, Yang J, Wang Y, Deng R. Recent advances in cardiovascular disease biosensors and monitoring technologies. ACS Sensors. 2023; 8(3):956–973. DOI: 10.1021/acssensors.2c02311
- Collinson P, Aakre KM, Saenger A, Body R, Hammarsten O, Jaffe AS, et al. Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB). Clinical Chemistry and Laboratory Medicine. 2023; 61(6):989–998. DOI: 10.1515/cclm-2022-1270
- Ferreira CE, França CN, Correr CJ, Zucker ML, Andriolo A, Scartezini M. Clinical correlations between a ponit-of-care testing system and laboratory automation for lipid profile. Clinica Chimica Acta. 2015; 446:263–266. DOI: 10.1016/j.cca.2015.04.036
- Cullen L, Collinson PO, Giannitsis E. Point-of-caretesting with high-sensitivity cardiac troponin assays: The challenges and opportunities. Emergency Medicine Journal. 2022; 39:861–866. DOI: 10.1136/emermed-2021-211907
- Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction. Journal of the American College of Cardiology. 2018; 72(6):620–632. DOI: 10.1016/j.jacc.2018.05.040
- Backus BE, Six AJ, Kelder JC, Bosschaert MA, Mast EG, Mosterd A, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. International Journal of Cardiology. 2013; 168(3):2153–2158. DOI: 10.1016/j.ijcard.2013.01.255
- Aakre KM, Apple FS, Mills NL, Meex SJR, Collinson PO, on behalf of the International Federation of Clinical Chemistry Committee on Clinical Applications of Cardiac Biomarkers (IFCC C-CB). Lower limits for reporting high-sensitivity cardiac troponin assays and impact of analytical performance on patient misclassification. Clinical Biochemistry. 2023; 70(3):497–505. DOI: 10.1093/clinchem/hvad185
- Xiong-Hang K, Schulz K, Sandoval Y, Smith SW, Saenger AK, Apple FS. Analytical performance comparing siemens whole blood point of care Atellica VTLi to the central laboratory plasma Atellica IM high-sensitivity cardiac troponin I assays. Clinical Biochemistry. 2023; 114:79–85. DOI: 10.1016/j.clinbiochem.2023.02.004
- Hammarsten O, Becker C, Engberg AE. Methods for analyzing positive cardiac troponin assay interference. Clinical Biochemistry. 2023; 116:24–30. DOI: 10.1016/j.clinbiochem.2023.03.004
- Denessen EJS, Nass SIJ, Bekers O, VroemeN WHM, Mingels AMA. Circulating forms of cardiac troponin: a review with implications for clinical practice. Journal of Laboratory and Precision Medicine. 2023; 8:1–11. DOI: 10.21037/jlpm-22-66
- Clerico A, Zaninotto M, Passino C, Padoan A, Migliardi M, Plebani M. High-sensitivity methods for cardiac troponins: The mission is not over yet. Advances in Clinical Chemistry. 2021; 103:215–252. DOI: 10.1016/bs.acc.2020.08.009
- de Barros e Silva PGM, Ferreira AA, Malafaia F, Reis AFMT, Sznejder H, Lopes Junior ACA, et al. Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: Main results of the IN-HOPE study. European Heart Journal Acute Cardiovascular Care. 2023; 12(11):755–764. DOI: 10.1093/ehjacc/zuad082
- Ferreira CES, Guerra JCC, Slhessarenko N, Scartezini M, França CN, Colombini MP, et al. Point-of-care testing: General aspects. Clinical Laboratory. 2018; 64(1):1–9. DOI: 10.7754/Clin.Lab.2017.170730
- Cullen L, Greenslade J, Parsonage W, Stephensen L, Smith SW, Sandoval Y, et al. Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h. European Heart Journal 2024; 00:1–8. DOI: 10.1093/eurheartj/ehae343
- Chaisirin W, Wongkrajang P, Thoesam T, Praphruetkit N, Nakornchai T, Riyapan S. Role of Point-of-Care Testing in Reducing Time to Treatment Decision-Making in Urgency Patients: A Randomized Controlled Trial. The Western Journal of Emergency Medicine. 2020; 21(2):404–410. DOI: 10.5811/westjem.2019.10.43655
- Erasmus R, Sahni S, El-Sharkawy R. Connectivity Strategies in Managing a POCT Service. EJIFCC. 2021; 32(2):190–194.
